CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
Publication
, Journal Article
Bashir, MR; Mendiratta-Lala, M
Published in: Radiology
May 2021
Duke Scholars
Published In
Radiology
DOI
EISSN
1527-1315
Publication Date
May 2021
Volume
299
Issue
2
Start / End Page
346 / 348
Location
United States
Related Subject Headings
- Tomography, X-Ray Computed
- Nuclear Medicine & Medical Imaging
- Magnetic Resonance Imaging
- Liver Neoplasms
- Humans
- Contrast Media
- Carcinoma, Hepatocellular
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bashir, M. R., & Mendiratta-Lala, M. (2021). CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear. Radiology, 299(2), 346–348. https://doi.org/10.1148/radiol.2021210049
Bashir, Mustafa R., and Mishal Mendiratta-Lala. “CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.” Radiology 299, no. 2 (May 2021): 346–48. https://doi.org/10.1148/radiol.2021210049.
Bashir MR, Mendiratta-Lala M. CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear. Radiology. 2021 May;299(2):346–8.
Bashir, Mustafa R., and Mishal Mendiratta-Lala. “CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.” Radiology, vol. 299, no. 2, May 2021, pp. 346–48. Pubmed, doi:10.1148/radiol.2021210049.
Bashir MR, Mendiratta-Lala M. CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear. Radiology. 2021 May;299(2):346–348.
Published In
Radiology
DOI
EISSN
1527-1315
Publication Date
May 2021
Volume
299
Issue
2
Start / End Page
346 / 348
Location
United States
Related Subject Headings
- Tomography, X-Ray Computed
- Nuclear Medicine & Medical Imaging
- Magnetic Resonance Imaging
- Liver Neoplasms
- Humans
- Contrast Media
- Carcinoma, Hepatocellular
- 3202 Clinical sciences
- 11 Medical and Health Sciences